End-of-day quote
Shanghai S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
6.79
CNY
|
-4.77%
|
|
+2.88%
|
-15.86%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
7,293
|
13,167
|
13,821
|
7,691
|
6,785
|
5,758
|
-
|
Enterprise Value (EV)
1 |
7,293
|
13,167
|
13,821
|
7,691
|
6,785
|
5,758
|
5,758
|
P/E ratio
|
9.55
x
|
15.3
x
|
16.1
x
|
28.3
x
|
38.4
x
|
11.1
x
|
6.93
x
|
Yield
|
-
|
2.13%
|
-
|
-
|
1.16%
|
3.09%
|
5.01%
|
Capitalization / Revenue
|
0.89
x
|
1.75
x
|
-
|
-
|
0.47
x
|
0.33
x
|
0.26
x
|
EV / Revenue
|
0.89
x
|
1.75
x
|
-
|
-
|
0.47
x
|
0.33
x
|
0.26
x
|
EV / EBITDA
|
-
|
8,919,075
x
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-6.42
x
|
1,919
x
|
6.81
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-15.6%
|
0.05%
|
14.7%
|
Price to Book
|
-
|
1.78
x
|
-
|
-
|
0.8
x
|
0.63
x
|
0.6
x
|
Nbr of stocks (in thousands)
|
675,939
|
805,309
|
847,929
|
847,944
|
840,806
|
847,949
|
-
|
Reference price
2 |
10.79
|
16.35
|
16.30
|
9.070
|
8.070
|
6.790
|
6.790
|
Announcement Date
|
4/15/20
|
4/19/21
|
4/21/22
|
4/20/23
|
4/26/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
8,150
|
7,545
|
-
|
-
|
14,584
|
17,548
|
22,087
|
EBITDA
|
-
|
1,476
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
1,038
|
-
|
-
|
75.51
|
614
|
988
|
Operating Margin
|
-
|
13.76%
|
-
|
-
|
0.52%
|
3.5%
|
4.47%
|
Earnings before Tax (EBT)
1 |
-
|
1,052
|
-
|
-
|
86.68
|
624
|
998
|
Net income
1 |
-
|
889.2
|
934.7
|
249.2
|
137.4
|
524
|
838
|
Net margin
|
-
|
11.79%
|
-
|
-
|
0.94%
|
2.99%
|
3.79%
|
EPS
2 |
1.130
|
1.070
|
1.010
|
0.3200
|
0.2100
|
0.6100
|
0.9800
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-1,057
|
3
|
845
|
FCF margin
|
-
|
-
|
-
|
-
|
-7.25%
|
0.02%
|
3.83%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
0.57%
|
100.84%
|
Dividend per Share
2 |
-
|
0.3480
|
-
|
-
|
0.0940
|
0.2100
|
0.3400
|
Announcement Date
|
4/15/20
|
4/19/21
|
4/21/22
|
4/20/23
|
4/26/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-1,057
|
3
|
845
|
ROE (net income / shareholders' equity)
|
-
|
13.7%
|
-
|
-
|
1.57%
|
5.7%
|
8.6%
|
ROA (Net income/ Total Assets)
|
-
|
8.58%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
10,364
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
9.190
|
-
|
-
|
10.00
|
10.70
|
11.30
|
Cash Flow per Share
|
-
|
1.560
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
2,394
|
-
|
-
|
2,210
|
1,500
|
1,000
|
Capex / Sales
|
-
|
31.73%
|
-
|
-
|
15.16%
|
8.55%
|
4.53%
|
Announcement Date
|
4/15/20
|
4/19/21
|
4/21/22
|
4/20/23
|
4/26/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -15.86% | 795M | | +1.20% | 67.05B | | +44.29% | 40.4B | | +15.99% | 38.64B | | +4.67% | 32.41B | | +6.59% | 19.17B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B | | -14.74% | 13.81B |
Other Commodity Chemicals
|